Log In
BCIQ
Print this Print this
 

Ferinject, Injectafer, ferric carboxymaltose (Z-213)

Also known as: VIT-45

  Manage Alerts
Collapse Summary General Information
Company Galenica Ltd.
DescriptionNon-dextran IV iron replacement
Molecular Target Not applicable
Mechanism of ActionRepletion therapy
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat iron deficiency anemia; Treat iron deficiency anemia in patients with non-dialysis dependent chronic kidney disease (CKD); Treat iron deficiency in patients with chronic heart failure (CHF); Treat iron deficiency in patients with fibromyalgia; Treat iron deficiency-related fatigue in non-anemic premenopausal women
Regulatory Designation
PartnerDaiichi Sankyo Co. Ltd.;
Fresenius SE & Co. KGaA;
Hikma Pharmaceuticals plc;
Zeria Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today